SMAD3 and cancer: Cell type-specific transcription factors60 and epigenomes61 can modulate SMAD3 downstream targets and therefore orchestrate cell type-specific effects of TGF-β signalling, a pathway which in cancer has dual roles in the regulation of cell death and proliferation depending on the context62.